Comparison of inpatient and outpatient palliative sedation practice - A prospective observational study.

Palliat Support Care

Clinic for Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Greifswald, Germany.

Published: August 2024

AI Article Synopsis

  • Palliative sedation (PS) is a medical approach to alleviate severe, untreatable symptoms in terminally ill patients, and requires thorough discussions with patients and families before implementation.
  • A study was conducted comparing PS in inpatient settings (palliative care unit) and outpatient settings (hospice and home care) from July 2017 to June 2018, focusing on demographics, sedation protocols, and satisfaction levels among staff and families.
  • Results showed that while inpatients were generally younger, both settings used midazolam for sedation with similar depth and satisfaction ratings, suggesting that PS can be effectively administered in either context.

Article Abstract

Introduction: Palliative sedation (PS) is an intrusive measure to relieve patients at the end of their life from otherwise untreatable symptoms. Intensive discussion of the advantages and limitations of palliative care with the patients and their relatives should precede the initiation of PS since PS is terminated by the patient's death in most cases. Drugs for PS are usually administered intravenously. Midazolam is widely used, either alone or in combination with other substances. PS can be conducted in both inpatient and outpatient settings; however, a quality analysis comparing both modalities was missing so far.

Patients And Methods: This prospective observational study collected data from patients undergoing PS inpatient at the palliative care unit (PCU,  = 26) or outpatient at a hospice ( = 2) or at home (specialized outpatient palliative care [SAPV],  = 31) between July 2017 and June 2018. Demographical data, indications for PS, and drug protocols were analyzed. The depth of sedation according to the Richmond Agitation Sedation Scale (RASS) and the degree of satisfaction of staff members and patient's relatives were included as parameters for quality assessment.

Results: Patients undergoing PS at the PCU were slightly younger compared to outpatients (hospice and SAPV combined). Most patients suffered from malignant diseases, and midazolam was the backbone of sedation for inpatients and outpatients. The median depth of sedation was between +1 and -3 according to the RASS with a trend to deeper sedation prior to death. The median degree of satisfaction was "good," scored by staff members and by patient's relatives. Significant differences between inpatients and outpatients were not seen in protocols, depth of sedation, and degree of satisfaction.

Conclusion: The data support the thesis that PS is possible for inpatients and outpatients with comparable results. For choosing the best place for PS, other aspects such as patient's and relative's wishes, stress, and medical reasons should be considered.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951522001523DOI Listing

Publication Analysis

Top Keywords

palliative care
12
depth sedation
12
inpatients outpatients
12
inpatient outpatient
8
outpatient palliative
8
sedation
8
palliative sedation
8
prospective observational
8
observational study
8
patients undergoing
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!